Companies: 10,795·Total market cap: $144.5T
Surmodics, Inc.

Surmodics, Inc.

SRDXNASDAQHealthcare
$42.98
+$0.15(+0.35%)
Market Cap$614511837
P/E Ratio
52W High$43.0048
52W Low$25.87

Surmodics, Inc. (SRDX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · SRDX · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

1

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Surmodics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

SRDX insider buying and selling by quarter

SRDX insider selling · SRDX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.6M786K0
2024 Q3
2024 Q4
2025 Q1
2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · SRDX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

SRDX executive sell shares · SRDX board member insider trading · SRDX insider trading SEC filing

Showing 30 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

OLSON CHARLES W

SVP, Medical Device Coatings

Other

Date

Nov 19

Shares

800

Price

$0.05

Value

$40

View Form 4 on SEC.gov

Manders John D.

VP Finance, Corp. Controller

Other

Date

Nov 19

Shares

8,155

Price

$0.05

Value

$408

View Form 4 on SEC.gov

Weber Gordon S.

Sr. VP of Legal, GC and Sec.

Other

Date

Nov 19

Shares

21,040

Price

$0.05

Value

$1K

View Form 4 on SEC.gov

SIDES TERI WOODWICK

SVP, Vascular Interventions

Other

Date

Nov 19

Shares

34,703

Price

$0.05

Value

$2K

View Form 4 on SEC.gov

DANTZKER DAVID

Director

Other

Date

Nov 19

Shares

40,183

Price

$0.05

Value

$2K

View Form 4 on SEC.gov

Heine Lisa Wipperman

Director

Other

Date

Nov 19

Shares

13,978

Price

$0.05

Value

$699

View Form 4 on SEC.gov

KNIGHT SUSAN E

Director

Other

Date

Nov 19

Shares

37,240

Price

$0.05

Value

$2K

View Form 4 on SEC.gov

BEDOYA JOSE H

Director

Other

Date

Nov 19

Shares

30,008

Price

$0.05

Value

$2K

View Form 4 on SEC.gov

Arens Timothy J.

CFO

Other

Date

Nov 19

Shares

67,299

Price

$0.05

Value

$3K

View Form 4 on SEC.gov

Stich Joseph J.

SVP of HR, President IVD

Other

Date

Nov 19

Shares

61,631

Price

$0.05

Value

$3K

View Form 4 on SEC.gov

Maharaj Gary R

President & CEO · Director

Other

Date

Nov 19

Shares

192,056

Price

$0.05

Value

$10K

View Form 4 on SEC.gov

Heine Lisa Wipperman

Director

Option

Date

Feb 18

Shares

2,640

Price

$27.30

Value

$72K

View Form 4 on SEC.gov

Heine Lisa Wipperman

Director

Other

Date

Feb 18

Shares

2,115

Price

$34.09

Value

$72K

View Form 4 on SEC.gov

DANTZKER DAVID

Director

Option

Date

Feb 13

Shares

5,275

Price

$27.30

Value

$144K

View Form 4 on SEC.gov

DANTZKER DAVID

Director

Other

Date

Feb 13

Shares

4,216

Price

$34.16

Value

$144K

View Form 4 on SEC.gov

BEDOYA JOSE H

Director

Option

Date

Feb 14

Shares

5,275

Price

$27.30

Value

$144K

View Form 4 on SEC.gov

BEDOYA JOSE H

Director

Other

Date

Feb 14

Shares

4,224

Price

$34.10

Value

$144K

View Form 4 on SEC.gov

KNIGHT SUSAN E

Director

Option

Date

Jan 24

Shares

7,358

Price

$27.30

Value

$201K

View Form 4 on SEC.gov

KNIGHT SUSAN E

Director

Other

Date

Jan 24

Shares

5,266

Price

$38.15

Value

$201K

View Form 4 on SEC.gov

Arens Timothy J.

CFO

Other

Date

Dec 4

Shares

1,265

Price

$39.91

Value

$50K

View Form 4 on SEC.gov

Weber Gordon S.

Sr. VP of Legal, GC and Sec.

Other

Date

Dec 4

Shares

668

Price

$39.91

Value

$27K

View Form 4 on SEC.gov

SIDES TERI WOODWICK

SVP, Vascular Interventions

Other

Date

Dec 4

Shares

946

Price

$39.91

Value

$38K

View Form 4 on SEC.gov

Manders John D.

VP Finance, Corp. Controller

Other

Date

Dec 4

Shares

152

Price

$39.91

Value

$6K

View Form 4 on SEC.gov

Stich Joseph J.

SVP of HR, President IVD

Other

Date

Dec 4

Shares

1,034

Price

$39.91

Value

$41K

View Form 4 on SEC.gov

OLSON CHARLES W

SVP, Medical Device Coatings

Other

Date

Dec 4

Shares

959

Price

$39.91

Value

$38K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About SRDX insider trading

SRDX insider trades

Surmodics, Inc. (SRDX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including OLSON CHARLES W (SVP, Medical Device Coatings), Manders John D. (VP Finance, Corp. Controller), Weber Gordon S. (Sr. VP of Legal, GC and Sec.). Over the past 12 months, 5 insiders have filed transactions with the SEC. SRDX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Surmodics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

SRDX insider trading · 5 questions

The insiders of Surmodics, Inc. (SRDX) include executives and directors such as OLSON CHARLES W (SVP, Medical Device Coatings), Manders John D. (VP Finance, Corp. Controller), Weber Gordon S. (Sr. VP of Legal, GC and Sec.), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

SRDX board member insider tradingwho are SRDX insidersSRDX insider rosterSurmodics, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026